Miyaki A, Yang P, Tai HH, Subbaramaiah K, Dannenberg AJ. Bile acids inhibit NAD ϩ -dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
A SUBSTANTIAL BODY OF EVIDENCE suggests that bile acids play a role in colorectal carcinogenesis. Epidemiological studies indicate that the risk of developing colon cancer is increased by consumption of a high-fat, low-fiber diet (37, 39, 45) and, following cholecystectomy (17, 41) , conditions that are associated with bile acid excess. Secondary bile acids are also increased in patients with colorectal adenomas (4) . Animal model studies have provided compelling evidence for a causal link between certain bile acids such as deoxycholate (DC) and colon carcinogenesis (31, 38, 43, 49) . A variety of mechanisms including activation of protein kinase C and stimulation of prostaglandin E 2 (PGE 2 ) production are believed to contribute to the procarcinogenic effects of bile acids (8, 16, 29, 64) .
Multiple findings suggest a significant role for PGs in colorectal carcinogenesis. Increased levels of PGE 2 are found in colorectal adenomas and cancers (35, 40) . Use of nonsteroidal anti-inflammatory drugs, prototypic inhibitors of cyclooxygenase (COX)-mediated synthesis of PGs, is associated with about a 50% reduction in risk of developing colon cancer (28, 51, 52) . Selective COX-2 inhibitors are effective inhibitors of sporadic colorectal adenoma formation (5) . An important role for PGE 2 also has been suggested by experimental studies. Mice engineered to be deficient in EP 2 , a receptor for PGE 2 , were protected against the development of intestinal tumors (42, 47) . In contrast, treatment of Apc Min/ϩ mice with exogenous PGE 2 increased the size and number of intestinal adenomas, especially in the colon (57) . Together, these findings strongly suggest that PGE 2 plays a significant role in the development of colorectal cancer. It is important, therefore, to define the mechanisms that account for increased amounts of PGE 2 in colorectal carcinogenesis. The mechanism(s) by which procarcinogenic bile acids induce PGE 2 production are incompletely understood.
The synthesis of PGE 2 from arachidonic acid requires two sequential enzymatic steps. COX catalyzes the synthesis of PGH 2 from arachidonic acid. COX-1 is a housekeeping gene that is expressed constitutively in most tissues, including the colon (46) . COX-2 is an immediate-early response gene that is induced by a variety of inflammatory and mitogenic stimuli, including bile acids (14, 25, 63, 64) . Microsomal prostaglandin E synthase-1 (mPGES-1) converts COX-derived PGH 2 to PGE 2 (26) . Both COX-2 and mPGES-1 are commonly overexpressed in colorectal adenomas and cancers (15, 33, 62) . Hence, increased synthesis of PGE 2 can explain, at least in part, the elevated levels of PGE 2 found in colorectal tumors. Tissue levels of PGE 2 depend on catabolism in addition to synthesis (24) . The key enzyme responsible for the metabolic inactivation of PGs, including PGE 2 , is nicotinamide adenine dinucleotide (NAD ϩ )-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) (24, 50) . This 29-kDa protein catalyzes the rate-limiting step of PG catabolism to yield 15-keto metabolites, which possess greatly reduced biological activities (50) . Markedly reduced amounts of 15-PGDH occur in multiple tumor types, including colorectal cancers, and contribute to elevated levels of intratumoral PGE 2 (2, 24, 30, 58, 59) . Importantly, the formation of colon tumors was markedly increased in 15-PGDH knockout mice, highlighting the significance of PG catabolism in tumorigenesis (32) .
In the present study, we showed that bile acids suppressed 15-PGDH transcription in colonocytes, which led, in turn, to increased production of PGE 2 . The reduction in 15-PGDH gene expression reflected activation of a signal transduction pathway comprising protein kinase C (PKC) 3 extracellular signal-regulated kinase (ERK1/2) 3 early growth response factor-1 (Egr-1) 3 Snail. Given the importance of both 15-PGDH and PGE 2 in colorectal carcinogenesis, our findings provide important new insights into the link between bile acids and colorectal carcinogenesis.
MATERIALS AND METHODS

Materials.
McCoy's 5A medium and fetal bovine serum (FBS) were purchased from Invitrogen (Grand Island, NY). RPMI 1640, Leibovitz's L-15 medium, and FBS were purchased from American Type Culture Collection (Manassas, VA). Anti-human polyclonal antiserum to 15-PGDH was purchased from Novus Biologicals (Littleton, CO). Anti-human polyclonal antiserum to Egr-1 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antihuman polyclonal antiserum to Snail was purchased from Abcam (Cambridge, MA). Antisera to ERK1/2 and phospho-ERK1/2 were purchased from Cell Signaling Technology (Beverly, MA). Antibody to ␤-actin, secondary antibody conjugated to horseradish peroxidase, bile acids, sodium arachidonate, calphostin C, PD-98059, L-glutamic dehydrogenase, ␣-ketoglutamic acid, and NAD ϩ were obtained from Sigma Chemical (St. Louis, MO). Western blot analysis detection reagents (ECL) and [ 32 P]ATP were obtained from PerkinElmer Life Sciences (Boston, MA). Nitrocellulose membranes were obtained from Schleicher and Schuell (Keene, NH). Charcoal-activated powder was obtained from EM Science (Gibbstown, NJ). Bicinchoninic acid (BCA) protein assay reagent was obtained from Pierce (Rockford, IL). The RNeasy mini kit was obtained from Qiagen (Valencia, CA). MuLV reverse transcriptase, RNase inhibitor, oligo (dT) 16 , and SYBR green PCR master mix were obtained from Applied Biosystems (Foster City, CA). DharmaFECT and all high-performance liquid chromatography-grade solvents were purchased from Thermo Fisher Scientific (Waltham, MA). The PKC assay kit was purchased from Millipore (Lake Placid, NY). The chromatin immunoprecipitation (ChIP) assay kit was purchased from SA Bioscience (Frederick, MD).
Cell culture. The human colon cancer cell lines HT29, HCT15, and SW480 were obtained from American Type Culture Collection. HT29 cells were maintained in McCoy's 5A medium supplemented with 10% FBS, 100 IU/ml penicillin, and 100 g/ml streptomycin. HCT15 cells were maintained in RPMI 1640 medium supplemented with 10% FBS, 100 IU/ml penicillin, and 100 g/ml streptomycin. SW480 cells were maintained in Leibovitz's L-15 medium supplemented with 10% FBS, 100 IU/ml penicillin, and 100 g/ml streptomycin. Cellular cytotoxicity was assessed by measurements of cell number, lactate dehydrogenase release, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. No evidence of cellular toxicity was detected in any of the experiments described below (data not shown).
Western blot analysis. Cell lysates were prepared by harvesting the cells using lysis buffer (150 mM NaCl, 100 mM Tris, pH 8.0, 1% Tween 20, 50 mM diethyldithiocarbamate, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 10 g/ml trypsin inhibitor, and 10 g/ml leupeptin). Lysates were sonicated for 20 s on ice and centrifuged at 10,000 g for 10 min at 4°C to remove the particulate material. The protein concentration of the lysates was measured using the BCA method. SDS-PAGE was performed under reducing conditions on 10% polyacrylamide gels. The resolved proteins were transferred onto nitrocellulose sheets and then probed for 15-PGDH, ERK1/2, phospho-ERK1/2, Egr-1, Snail, and ␤-actin using previously described methods (48) .
15-PGDH activity assay. 15-PGDH enzyme activity in cellular lysates was assayed by measuring the transfer of tritium from 15(S)- [15- 3 H]PGE2 to glutamate by coupling 15-PGDH with glutamate dehydrogenase as described previously (53) .
Real-time PCR. Total RNA was isolated using the RNeasy mini kit. One g RNA was reversed transcribed using murine leukemia virus reverse transcriptase (Roche Applied Science, Indianapolis, IN) and oligo (dT) 16 primer. The resulting cDNA was then used for amplification. The volume of the PCR was 20 l and contained 5 l of cDNA with the following primers: 15-PGDH (forward, 5Ј-TCTGTTCATC-CAGTGCGATGT-3Ј and reverse, 5Ј-ATAATGATGCCGCCTTCA-CCT-3Ј), Egr-1 (forward, 5Ј-GCGACATCTGTGGAAGAAAGTTT-GCC-3Ј and reverse, 5Ј-TTTCTTGTCCTTCTGCCGCAAGTG-3Ј), and Snail (forward, 5Ј-TCCCTCTTCCTCTCCATACCTG-3Ј and reverse, 5Ј-ATGGCAGTGAGAAGGATGTGG-3Ј). Real-time PCR was performed using 2ϫ SYBR green PCR master mix on a 7900 HT real-time PCR system (Applied Biosystems) with ␤-actin (forward 5Ј-AGAAAATCTGGCACCACACC-3Ј and reverse 5Ј-AGAGGCG-TACAGGGATAGCA-3Ј) serving as an endogenous normalization control. Relative fold induction was determined using the ⌬⌬C T (relative quantification) analysis protocol.
Transient transfections. Egr-1 small interfering RNA (siRNA), Snail siRNA, and nonspecific siRNA were obtained from Dharmacon. HCT15 cells were transfected with 100 nM of siRNA using Dharma-FECT transfection reagent according to the manufacturer's instructions. After transfection for 36 h, the cells were collected for analysis or treatment.
Determination of PG levels. Levels of PGs were quantified by liquid chromatography/tandem mass spectroscopic analyses using previously described methods (24) .
PKC activity. The activity of PKC was measured according to instructions from Millipore. Briefly, cells were plated in 10-cm dishes at 10 6 cells/dish and grown to 60% confluence. Cells were then treated with 0 -100 M chenodeoxycholate (CD) for 10 min. Total PKC activity was measured in cell lysates. To determine cytosolic and membrane-bound PKC activity, we centrifuged cell lysates at 100,000 g for 30 min. The resulting supernatant contains cytosolic PKC; membrane-bound PKC activity is present in the pellet. The system is based on PKC-catalyzed transfer of [␥- 32 P]ATP to a PKC-specific peptide.
ChIP assay. ChIP assay was performed with a kit according to the manufacturer's instructions. Briefly, 4 ϫ 10 6 cells were cross-linked in a 1% formaldehyde solution at 37°C for 10 min. Cells were then lysed and sonicated to generate 200-to 1,000-bp DNA fragments. After centrifugation, the cleared supernatant was incubated with 4 g of the indicated antibody at 4°C overnight. Immune complexes were precipitated, washed, and eluted as recommended. DNA-protein cross-links were reversed by heating at 65°C for 4 h, and the DNA fragments were purified and used as a template for PCR amplification. Quantitative real-time PCR was carried out. 15-PGDH promoter oligonucleotide sequences for PCR primers were forward, 5Ј-CTC-CGCTCTCCTTCTATCCA-3Ј and reverse, 5Ј-AACCCACGACTGT-GTCACCT-3Ј. This primer set encompasses the 15-PGDH promoter sequence from nucleotide Ϫ366 to Ϫ155. PCR was performed at 94°C for 30 s, 62°C for 30 s, and 72°C for 45 s for 35 cycles, and real-time PCR was performed at 95°C for 15 s and 60°C for 60 s for 40 cycles. The PCR product generated from the ChIP template was sequenced, and the identity of the 15-PGDH promoter was confirmed.
Statistics. Each experiment was performed at least three times. Comparisons between groups were made using Student's t-test. A difference between groups of P Ͻ 0.05 was considered significant.
RESULTS
Unconjugated bile acids inhibit the expression of 15-PGDH.
Initially, we investigated whether treatment with CD or DC altered the expression of 15-PGDH. As shown in Fig. 1A , both CD and DC caused dose-dependent suppression of levels of 15-PGDH protein in several human colon cancer cell lines.
Consistent with these findings, treatment with CD or DC also led to a dose-dependent decrease in 15-PGDH activity (Fig.  1B) . Quantitative real-time PCR was performed to determine the effects of CD and DC on amounts of 15-PGDH mRNA.
Treatment with either unconjugated bile acid led to a marked reduction in levels of 15-PGDH mRNA (Fig. 1C) . 15-PGDH catalyzes the conversion of PGE 2 to 15-keto-PGE 2 . To evaluate whether bile acid-mediated downregulation of 15-PGDH had functional consequences, we next evaluated whether treatment with CD altered the production of either PGE 2 or 15-keto-PGE 2 . Treatment with CD led to a marked increase in the amount of PGE 2 produced with a reciprocal decrease in the formation of 15-keto-PGE 2 (Fig. 1D) .
Previously, conjugated bile acids were found to be less potent inducers of COX-2 than unconjugated bile acids (56, 63, 64) . Hence, it was of interest to evaluate the effects of conjugated bile acids [glycochenodeoxycholate (GCD), taurochenodeoxycholate (TCD), glycodeoxycholate (GDC), and taurodeoxycholate (TDC)] on the expression and activity of 15-PGDH. As shown in Fig. 2A , high concentrations of conjugated bile acids were required to downregulate 15-PGDH. We also compared the effects of unconjugated and conjugated bile acids. Unconjugated bile acids (CD and DC) were much more potent inhibitors of 15-PGDH expression and activity than related conjugated bile acids (Fig. 2, B and C) . Treatment with . Columns, means (n ϭ 4); bars, SD. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001. C: HT29 and HCT15 cells were treated with indicated concentrations of CD and DC for 20 h. Total RNA was isolated, and quantitative real-time PCR was performed. Values of 15-PGDH mRNA were normalized to values obtained for ␤-actin. Columns, means (n ϭ 4); bars, SD. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001. D: HT29 cells were treated with vehicle or 100 M CD. Twenty-four hours later, the medium was replaced with fresh medium containing 10 M sodium arachidonate for 30 min. The medium was then collected and analyzed for amounts of PGE2 and 15-keto-PGE2, respectively. Columns, means (n ϭ 6); bars, SD. *P Ͻ 0.05; **P Ͻ 0.01. unconjugated bile acids also caused a marked reduction of 15-PGDH mRNA compared with conjugated bile acids (data not shown).
Bile acids activate the PKC 3 ERK1/2 pathway, resulting in suppression of 15-PGDH transcription. Bile acids have been reported to activate cell signaling by stimulating the redistribution of PKC activity from cytosol to membrane (21, 27) . As shown in Fig. 3A , treatment with CD led to a concentrationdependent translocation of PKC activity from cytosol to membrane. Next, we investigated whether increased membrane PKC activity was causally linked to CD-mediated downregulation of 15-PGDH. Treatment with calphostin C, an inhibitor of PKC activity, attenuated the suppressive effects of CD on 15-PGDH expression (Fig. 3B) . Together, these results suggest that CD-mediated activation of PKC signaling is linked to the suppression of 15-PGDH levels. Activation of PKC signaling can stimulate ERK1/2 MAPK. As shown in Fig. 3C , treatment with CD caused a rapid concentration-dependent increase in ERK1/2 activity. In contrast, similar concentrations of conjugated bile acids (GCD and TCD) did not stimulate ERK1/2 phosphorylation (data not shown). Importantly, treatment with PD-98059, a compound that blocks the activation of ERK1/2, suppressed CD-mediated downregulation of 15-PGDH (Fig.  3D ). This implies that the observed increase in ERK1/2 activity following bile acid treatment contributes to the suppression of 15-PGDH expression. To confirm that CD-mediated activation of PKC led to the observed increase in ERK1/2 activity, we determined the effects of calphostin C. As shown in Fig. 3E , treatment with calphostin C blocked CD-mediated stimulation of ERK1/2 activity. The transcription factor Snail was recently found to repress the transcription of 15-PGDH (3, 30) . The expression of Snail is positively regulated by Egr-1, which, in turn, can be induced by ERK1/2 (20) . To investigate whether bile acids induce Egr-1 and Snail, we carried out immunoblot analyses. Treatment with CD induced levels of both Egr-1 and Snail protein in a dose-and time-dependent manner (Fig. 4, A  and B) . The induction of Egr-1 occurred before the increase in levels of Snail. To determine whether regulation was pretranslational, we quantified levels of Egr-1 and Snail mRNAs. Consistent with the observed increase in Egr-1 and Snail protein levels, treatment with CD induced Egr-1 and Snail mRNAs (Fig. 4, C and D) . Once again, the increase in Egr-1 message preceded the induction of Snail mRNA. We next investigated whether bile acid-mediated activation of the PKC 3 ERK1/2 pathway was causally linked to the induction of Egr-1 and Snail. Treatment with calphostin C or PD-98059 blocked CD-mediated induction of Egr-1 and Snail (Fig. 4, E  and F) . Next, it was important to determine whether the induction of Egr-1 by CD was responsible for the increased levels of Snail and reduced amounts of 15-PGDH. Silencing of Egr-1 (Fig. 5A) blocked CD-mediated induction of Snail (Fig.  5B) . Importantly, silencing of Egr-1 also blocked CD-mediated downregulation of 15-PGDH (Fig. 5C) .
To further evaluate the potential role of Snail in regulating 15-PGDH expression, it was important to determine whether CD stimulated the binding of Snail to the 15-PGDH promoter. Snail previously has been reported to bind to a region of the 15-PGDH promoter that contains E-boxes (30) . ChIP assays were carried out using a primer set that included the 15-PGDH promoter segment containing E-boxes. As shown in Fig. 6A , treatment with CD caused a 1.5-fold increase in the binding of Snail to the 15-PGDH promoter. It was next important to evaluate whether Snail was important for CD-mediated downregulation of 15-PGDH expression. Silencing of Snail (Fig.  6B) blocked CD-mediated downregulation of 15-PGDH (Fig.   Fig. 3 . CD mediated activation of PKC 3 ERK1/2 leads to reduced levels of 15-PGDH. A: HCT15 cells were treated with 0 -100 M CD for 10 min. Total PKC activity, cytosolic PKC activity, and membrane PKC activity were measured. Columns, means (n ϭ 6); bars, SD. **P Ͻ 0.01; ***P Ͻ 0.001. B: HCT15 cells were pretreated with calphostin C (0 -2 M, 2 h), and then vehicle or CD (50 M) was added for 12 h. Cellular protein (100 g/lane) was loaded onto a 10% SDS-polyacrylamide gel, electrophoresed, and subsequently transferred onto nitrocellulose membranes. Immunoblot was probed with antibodies specific for 15-PGDH and ␤-actin. C: HCT15 cells were treated with 0 -100 M CD for 15 or 30 min. Cellular lysate protein (100 g/lane) was loaded onto a 10% SDS-polyacrylamide gel, electrophoresed, and subsequently transferred onto nitrocellulose membranes. Immunoblots were probed with antibodies specific for phospho-ERK1/2 and ERK1/2. D: HCT15 cells were pretreated with PD-98059 (0 -100 M, 2 h), and then vehicle or CD (50 M) was added for 12 h. Cellular protein (100 g/lane) was loaded onto a 10% SDS-polyacrylamide gel, electrophoresed, and subsequently transferred onto nitrocellulose membranes. Immunoblot was probed with antibodies specific for 15-PGDH and ␤-actin. E: HCT15 cells were pretreated with vehicle or 2 M calphostin C for 2 h, and then vehicle or 100 M CD was added for 15 or 30 min. Cellular protein (100 g/lane) was loaded onto a 10% SDS-polyacrylamide gel, electrophoresed, and subsequently transferred onto nitrocellulose membranes. The immunoblot was probed with antibodies specific for phospho-ERK1/2 and ERK1/2. 6C). Together, these results suggest that bile acid-mediated activation of the PKC 3 ERK1/2 3 Egr-1 3 Snail pathway is responsible for the downregulation of 15-PGDH transcription.
DISCUSSION
Multiple lines of evidence suggest that PGs play a key role in gastrointestinal mucosal homeostasis, colitis, and colon carcinogenesis (30, 34, 35, 40, 48, 57) . It is important, therefore, to understand the endogenous factors that regulate PG production. In humans, intracolonic release of PGs is stimulated by exposure to bile acid (7, 36) . Previously, we found that unconjugated bile acids were potent inducers of COX-2 and PG synthesis (56, 63, 64 ). In the current study, we have shown that unconjugated bile acids suppress the transcription of 15-PGDH, resulting in increased production of PGE 2 and reduced synthesis of 15-keto-PGE 2 .
Recent studies have suggested that 15-PGDH, the key enzyme responsible for metabolic inactivation of PGs, behaves as a tumor suppressor for several tumor types, including colon cancer (11, 32, 58, 59) . Bile acid-mediated suppression of 15-PGDH, which results in increased levels of PGs, could be important for both the formation and progression of gastrointestinal cancers. In support of this notion, PGE 2 stimulates cell proliferation, promotes angiogenesis, and inhibits apoptosis and immune surveillance (9, 18, 23, 44) . PGE 2 also can induce cell invasion and an epithelial mesenchymal transition (12, 19, 54, 55, 61) , processes linked to metastasis. The potential significance of bile acid-mediated downregulation of 15-PGDH is underscored by extensive evidence that either inhibiting the synthesis of PGE 2 or antagonizing its actions can suppress carcinogenesis (5, 28, 42, 47, 51, 52) .
Bile acid-mediated suppression of 15-PGDH transcription reflected activation of the PKC 3 ERK1/2 3 Egr-1 3 Snail signal transduction pathway. The involvement of PKC is suggested by two findings. Consistent with prior reports (21, 27) , membranous PKC activity was stimulated by bile acid treatment. Importantly, bile acid-mediated suppression of 15-PGDH was attenuated by treatment with an inhibitor of PKC activity. Additional studies are needed to determine which isoforms of PKC are involved. The involvement of ERK1/2 is supported by two findings. First, treatment with bile acid led to rapid activation of ERK1/2. Second, an inhibitor of MAPK kinase blocked bile acid-mediated downregulation of 15-PGDH. An inhibitor of PKC activity blocked bile acid-mediated activation of ERK1/2, suggesting that PKC is upstream of ERK1/2. and Snail mRNA (D) were normalized to values obtained for ␤-actin. Columns, means (n ϭ 4); bars, SD. *P Ͻ 0.05; **P Ͻ 0.01. E: HCT15 cells were pretreated with vehicle or 2 M calphostin C for 2 h. Subsequently, vehicle or 50 M CD was added for 3 h. Cellular protein (100 g/lane) was loaded onto a 10% SDS-polyacrylamide gel, electrophoresed, and subsequently transferred onto nitrocellulose membranes. Immunoblots were probed with antibodies specific for Egr-1, Snail, and ␤-actin. F: HCT15 cells were pretreated with vehicle or 100 M PD-98059 for 2 h, and then vehicle or 50 M CD was added for 3 h. Cellular protein (100 g/lane) was loaded onto a 10% SDSpolyacrylamide gel, electrophoresed, and subsequently transferred onto nitrocellulose membranes. Immunoblots were probed with antibodies specific for Egr-1, Snail, and ␤-actin.
We also report that suppression of 15-PGDH reflects bile acid-mediated induction of Egr-1 and Snail. Recently, activation of MAPK was found to induce Egr-1 leading, in turn, to increased Snail expression (20) . Moreover, bile acids have been reported to induce Egr-1 and Snail, a known repressor of 15-PGDH transcription in colonocytes (6, 30) . Treatment with bile acid led to increased levels of Egr-1 and Snail message and protein. Importantly, the increase in Egr-1 preceded the change in Snail expression. The induction of Egr-1 and Snail by bile acid was suppressed by treatment with inhibitors of PKC or MAPK kinase. Bile acid-mediated induction of Snail and suppression of 15-PGDH expression was blocked by silencing of Egr-1. Previous studies have reported that the transcriptional repressor Snail binds to E-boxes in the 15-PGDH promoter and thereby inhibits transcription (30) . There are three E-boxes located in the 15-PGDH 5Ј-flanking region. ChIP analysis indicated that treatment with bile acid stimulated the binding of Snail to a region of the 15-PGDH promoter containing the three E-boxes. To evaluate the functional significance of increased Snail binding, we used siRNA. Silencing of Snail blocked bile acid-mediated downregulation of 15-PGDH.
Both conjugated and unconjugated bile acids caused a reduction in 15-PGDH expression and activity. However, unconjugated bile acids were much more potent than conjugated bile acids. This finding is consistent with our previous results for COX-2 (56, 63, 64) . Notably, the concentrations of unconjugated bile acids that suppressed levels of 15-PGDH are found in the aqueous phase of the fecal stream (10, 22) . The observed difference in suppressive activity is likely to reflect differences in the hydrophobicity of unconjugated and conjugated bile acids. CD and DC are hydrophobic bile acids. Conjugation of these bile acids with either glycine or taurine makes them more hydrophilic and less potent inhibitors of 15-PGDH expression. These findings are consistent with recent evidence that the ability to bile acids to activate PKC␣ and ERK1/2 is hydrophobicity dependent (1). Levels of 15-PGDH are markedly reduced in both inflammatory bowel disease and colorectal cancer (2, 34, 59) . A number of different mechanisms can downregulate 15-PGDH transcription. Hypermethylation of the 15-PGDH promoter, changes in histone acetylation, and increased binding of repressive transcription factors, including Snail, lead to reduced transcription (3, 30, 58, 60) . Future studies are needed to determine whether bile acids induce epigenetic changes such as hypermethylation of the 15-PGDH promoter that also contribute to reduced expression. Our data suggest that bile acids can suppress levels of 15-PGDH, which could, in turn, promote the development of colorectal cancer. Recently, inducers of 15-PGDH have been proposed as potential chemopreventive agents (13) . On the basis of this study, it would be worthwhile to determine whether agents that block bile acid-mediated downregulation of 15-PGDH possess anticancer properties. Chromatin fragments were immunoprecipitated with antibodies against Snail, and the 15-PGDH promoter was amplified by PCR (top) or real-time PCR (bottom). DNA sequencing was carried out, and the PCR product was confirmed to be the 15-PGDH promoter. The 15-PGDH promoter was not detected when normal IgG was used or when antibody was omitted from the immunoprecipitation step (data not shown). Values are means Ϯ SD; n ϭ 3. *P Ͻ 0.05. B and C: HCT15 cells were transfected with 100 nM Snail siRNA or nonspecific control siRNA. After transfection, cells were treated with vehicle or 50 M CD for 12 h. Cellular protein (100 g/lane) was loaded onto a 10% SDS-polyacrylamide gel, electrophoresed, and subsequently transferred onto nitrocellulose membranes. Immunoblots were probed as indicated with antibodies specific for Snail, 15-PGDH, and ␤-actin.
